← Leaderboards
Gretchen Lano Birbeck
University Of Rochester
$12,919,100
Attributed
$15,417,953
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,417,953 · 11
By mechanism
R01$10,784,435 · 5
R35$2,561,391 · 1
R21$1,274,252 · 4
K23$797,875 · 1
Top collaborators
- Michael James Potchen10 shared
- Izukanji Sikazwe6 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Michael James Potchen$987,850
- Rebecca Tucker$22,949
Others in their field
Top investigators on “Child”
- Barbara Driver · Westat, Inc.$244,454,458
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$195,214,889
- George R Seage · Abt Associates, Inc.$189,009,744
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$170,579,744
Research focus
ChildNeurologicZambiaRisk FactorsMalawiSeizuresInsightAcuteAfricanChildhoodMalariaPharmaceutical PreparationsResourcesBaseBrainEnrollmentCaringAfricaProgramsEpilepsyChronicDesignScale UpCessation Of Life
Grant awards (46)
Global Research Endeavors to Advance Treatment of Neurological Disorders in Africa (GREAT Neurology)$533,982
R35 · FY2025 · NS · contact PI
Global Research Endeavors to Advance Treatment of Neurological Disorders in Africa (GREAT Neurology)$530,560
R35 · FY2024 · NS · contact PI
An MRI Ancillary Study of Malaria Fever Control RCT$194,499
R01 · FY2024 · NS · contact PI
Global Research Endeavors to Advance Treatment of Neurological Disorders in Africa (GREAT Neurology)$527,167
R35 · FY2023 · NS · contact PI
An MRI Ancillary Study of Malaria Fever Control RCT$245,515
R01 · FY2023 · NS · contact PI
Global Research Endeavors to Advance Treatment of Neurological Disorders in Africa (GREAT Neurology)$521,882
R35 · FY2022 · NS · contact PI
An MRI Ancillary Study of Malaria Fever Control RCT$246,609
R01 · FY2022 · NS · contact PI
Aggressive Antipyretics in CNS Malaria: A Randomized-Controlled Trial Assessing Antipyretic Efficacy and Parasite Clearance$602,537
R01 · FY2021 · NS · contact PI
Global Research Endeavors to Advance Treatment of Neurological Disorders in Africa (GREAT Neurology)$447,800
R35 · FY2021 · NS · contact PI
An MRI Ancillary Study of Malaria Fever Control RCT$282,665
R01 · FY2021 · NS · contact PI
Collaborative HIV Investigations of Antiretroviral Neuropsychiatric Toxicities in Zambia (CHANTZ): Protease Inhibitor Impact on Pediatric Cerebrovasculature and Mood$165,809
R21 · FY2021 · MH · contact PI
Aggressive Antipyretics in CNS Malaria: A Randomized-Controlled Trial Assessing Antipyretic Efficacy and Parasite Clearance$638,757
R01 · FY2020 · NS · contact PI
An MRI Ancillary Study of Malaria Fever Control RCT$317,456
R01 · FY2020 · NS · contact PI
Collaborative HIV Investigations of Antiretroviral Neuropsychiatric Toxicities in Zambia (CHANTZ): Protease Inhibitor Impact on Pediatric Cerebrovasculature and Mood$232,830
R21 · FY2020 · MH · contact PI
En Route to a Career in Clinical Research: Early Engagement in Clinical Trials and Premedical Curriculum Completion$56,342
R01 · FY2020 · NS · contact PI
Aggressive Antipyretics in CNS Malaria: A Randomized-Controlled Trial Assessing Antipyretic Efficacy and Parasite Clearance$644,309
R01 · FY2019 · NS · contact PI
Cohort of HIV-Associated Seizures and Epilepsy in Zambia (CHASE): Scale up and expansion informed by R21 Findings$575,052
R01 · FY2019 · NS · contact PI
Cohort of HIV-Associated Seizures and Epilepsy in Zambia (CHASE): Scale up and expansion informed by R21 Findings$137,626
R01 · FY2019 · NS · contact PI
Aggressive Antipyretics in CNS Malaria: A Randomized-Controlled Trial Assessing Antipyretic Efficacy and Parasite Clearance$631,073
R01 · FY2018 · NS · contact PI
Cohort of HIV-Associated Seizures and Epilepsy in Zambia (CHASE): Scale up and expansion informed by R21 Findings$563,751
R01 · FY2018 · NS · contact PI
Aggressive Antipyretics in CNS Malaria: A Randomized-Controlled Trial Assessing Antipyretic Efficacy and Parasite Clearance$690,395
R01 · FY2017 · NS · contact PI
Cohort of HIV-Associated Seizures and Epilepsy in Zambia (CHASE): Scale up and expansion informed by R21 Findings$560,900
R01 · FY2017 · NS · contact PI
Cohort of HIV-Associated Seizures and Epilepsy in Zambia (CHASE): Scale up and expansion informed by R21 Findings$565,572
R01 · FY2016 · NS · contact PI
Cohort of HIV-Associated Seizures and Epilepsy in Zambia (CHASE): Scale up and expansion informed by R21 Findings$619,107
R01 · FY2015 · NS · contact PI
A Dose-Escalation, Safety and Feasibility Study of Enteral Levetiracetam for Seizure Control in Pediatric Cerebral Malaria$547,047
R01 · FY2014 · NS · contact PI
A Dose-Escalation, Safety and Feasibility Study of Enteral Levetiracetam for Seizure Control in Pediatric Cerebral Malaria$572,301
R01 · FY2013 · NS · contact PI
A DOSE-ESCALATION, SAFETY AND FEASIBILITY STUDY OF ENTERAL LEVETIRACETAM FOR SEIZ$712,227
R01 · FY2012 · NS · contact PI
Epilepsy-associated stigma in Zambia: Evidence-based interventions and outcomes$258,131
R01 · FY2012 · NS · contact PI
A Cohort Study of Seizures and Epilepsy in HIV+ Zambian Adults$118,992
R21 · FY2012 · NS · contact PI
Epilepsy-associated stigma in Zambia: Evidence-based interventions and outcomes$258,376
R01 · FY2011 · NS · contact PI
A Cohort Study of Seizures and Epilepsy in HIV+ Zambian Adults$125,758
R21 · FY2011 · NS · contact PI
THE MALAWI-MSU MRI PROJECT: AN EPIDEMIOLOGIC STUDY OF CNS ABNORMALITIES$113,064
R21 · FY2011 · NS · contact PI
Epilepsy-associated stigma in Zambia: Evidence-based interventions and outcomes$260,140
R01 · FY2010 · NS · contact PI
THE MALAWI-MSU MRI PROJECT: AN EPIDEMIOLOGIC STUDY OF CNS ABNORMALITIES$123,091
R21 · FY2010 · NS · contact PI
Epilepsy-associated stigma in Zambia: Evidence-based interventions and outcomes$62,029
R01 · FY2010 · NS · contact PI
THE MALAWI-MSU MRI PROJECT: AN EPIDEMIOLOGIC STUDY OF CNS ABNORMALITIES$54,161
R21 · FY2010 · NS · contact PI
Epilepsy-associated stigma in Zambia: Evidence-based interventions and outcomes$265,973
R01 · FY2009 · NS · contact PI
Epilepsy-associated stigma in Zambia: Evidence-based interventions and outcomes$276,046
R01 · FY2008 · NS · contact PI
Is Cerebral Malaria a Risk Factor for Epilepsy?$159,575
K23 · FY2008 · NS · contact PI
Is Cerebral Malaria a Risk Factor for Epilepsy?$159,575
K23 · FY2007 · NS · contact PI
Is Cerebral Malaria a Risk Factor for Epilepsy?$159,575
K23 · FY2006 · NS · contact PI
Is Cerebral Malaria a Risk Factor for Epilepsy?$159,575
K23 · FY2005 · NS
Epilepsy-associated stigma in Zambia$107,357
R21 · FY2005 · NS
Is Cerebral Malaria a Risk Factor for Epilepsy?$159,575
K23 · FY2004 · NS
Epilepsy-associated stigma in Zambia$112,719
R21 · FY2004 · NS
Epilepsy-associated stigma in Zambia$120,471
R21 · FY2003 · NS